Ignite Creation Date:
2024-05-05 @ 5:05 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00389779
Status:
COMPLETED
Last Update Posted:
2014-03-18
First Post:
2006-10-17
Brief Title:
DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension
Sponsor:
Gilead Sciences
Organization:
Gilead Sciences
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-09
Start Date Type:
None
Primary Completion Date:
2009-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-08
Completion Date Type:
ACTUAL
First Submit Date:
2006-10-17
First Submit QC Date:
October 18 2006
Study First Post Date:
2006-10-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2014-01-03
Disp First Submit QC Date:
January 3 2014
Disp First Post Date:
2014-02-04
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2014-02-19
Last Update Post Date:
2014-03-18
Last Update Post Date Type:
ESTIMATED